Group 3 Flashcards

(23 cards)

1
Q

What is the source of heptavalent botulism antitoxin?

A

Derived from equine plasma (horse serum).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which botulinum neurotoxin serotypes does the heptavalent antitoxin target?

A

Serotypes A, B, C, D, E, F, and G.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does the heptavalent antitoxin work?

A

Binds to botulinum neurotoxins, blocking their interaction with nerve endings and preventing neurotransmitter inhibition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does the heptavalent antitoxin work?

A

Binds to botulinum neurotoxins, blocking their interaction with nerve endings and preventing neurotransmitter inhibition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the adult dosage regimen for heptavalent antitoxin?

A

One vial IV, starting at 0.5 mL/min, increasing to max 2 mL/min.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What caution is critical during administration?

A

Monitor for hypersensitivity reactions (e.g., anaphylaxis) and infusion-related complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What advantage do human-derived antitoxins have over equine-based ones?

A

Lower hypersensitivity risk (e.g., BabyBIG® for infant botulism).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How are monoclonal antibodies (mAbs) for botulism produced?

A

Engineered in CHO/human cell lines via recombinant DNA technology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the key benefits of monoclonal antibodies?

A

Consistent potency, fewer side effects, and precise serotype targeting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the infant dosage for human-derived antitoxin (e.g., BabyBIG®)?

A

50 mg/kg IV (1 mL/kg), infused at 0.5 mL/kg/hr.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name two investigational uses of botulism antitoxins.

A

Post-exposure prophylaxis (bioterrorism) and inhalational botulism treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are common sources of IPA toxicity?

A

Hand sanitizers, rubbing alcohol, household cleaners, and cosmetics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is IPA’s mechanism of toxicity?

A

Denatures proteins, disrupts cell membranes, causes CNS depression, and metabolic acidosis (via acetone).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the toxic dose of IPA for adults?

A

~240 mL (acute ingestion).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are severe symptoms of IPA poisoning?

A

Respiratory depression, hypotension, coma, and metabolic acidosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is IPA poisoning managed?

A

Supportive care, activated charcoal (if <1 hour post-ingestion), fluid resuscitation, and hemodialysis in severe cases.

17
Q

What contraindication applies to IPA use?

A

Pregnancy/lactation (risk of fetal harm or breast milk transfer).

18
Q

Why is flammability a caution for IPA?

A

Highly flammable; requires storage away from heat sources.

19
Q

What monitoring is needed during heptavalent antitoxin infusion?

A

Vital signs for hypersensitivity reactions and infusion rate adjustments.

20
Q

What is a key difference between human-derived and equine antitoxins?

A

Human-derived antitoxins use pathogen-screened plasma from vaccinated donors.

21
Q

What lab test interference does heptavalent antitoxin cause?

A

Glucose-specific testing systems may yield inaccurate results.

22
Q

What plant-derived toxins cross-react with Digoxin Immune Fab?

A

Pheasant’s eye, balloon cotton bush, and toad venom (off-label use).

23
Q

What is a major complication of IPA toxicity?

A

Severe metabolic acidosis requiring hemodialysis.